Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 366

1.

Selenium supplementation for patients with Graves' hyperthyroidism (the GRASS trial): study protocol for a randomized controlled trial.

Watt T, Cramon P, Bjorner JB, Bonnema SJ, Feldt-Rasmussen U, Gluud C, Gram J, Hansen JL, Hegedüs L, Knudsen N, Bach-Mortensen P, Nolsøe R, Nygaard B, Pociot F, Skoog M, Winkel P, Rasmussen AK.

Trials. 2013 Apr 30;14:119. doi: 10.1186/1745-6215-14-119.

PMID:
23782950
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

The chronic autoimmune thyroiditis quality of life selenium trial (CATALYST): study protocol for a randomized controlled trial.

Winther KH, Watt T, Bjørner JB, Cramon P, Feldt-Rasmussen U, Gluud C, Gram J, Groenvold M, Hegedüs L, Knudsen N, Rasmussen ÅK, Bonnema SJ.

Trials. 2014 Apr 9;15:115. doi: 10.1186/1745-6215-15-115.

PMID:
24716668
[PubMed - in process]
Free PMC Article
3.

Is there a methimazole dose effect on remission rate in Graves' disease? Results from a long-term prospective study. The European Multicentre Trial Group of the Treatment of Hyperthyroidism with Antithyroid Drugs.

Benker G, Reinwein D, Kahaly G, Tegler L, Alexander WD, Fassbinder J, Hirche H.

Clin Endocrinol (Oxf). 1998 Oct;49(4):451-7.

PMID:
9876342
[PubMed - indexed for MEDLINE]
4.

Sustained control of Graves' hyperthyroidism during long-term low-dose antithyroid drug therapy of patients with severe Graves' orbitopathy.

Laurberg P, Berman DC, Andersen S, Bülow Pedersen I.

Thyroid. 2011 Sep;21(9):951-6. doi: 10.1089/thy.2011.0039. Epub 2011 Aug 11.

PMID:
21834677
[PubMed - indexed for MEDLINE]
5.

Total versus near-total thyroidectomy in Graves' disease and their outcome on postoperative transient hypoparathyroidism: study protocol for a randomized controlled trial?

Maschuw K, Schlosser K, Lubbe D, Nies C, Bartsch DK.

Trials. 2012 Dec 6;13:234. doi: 10.1186/1745-6215-13-234.

PMID:
23216901
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

Diagnosis and treatment of Graves disease.

Streetman DD, Khanderia U.

Ann Pharmacother. 2003 Jul-Aug;37(7-8):1100-9. Review.

PMID:
12841824
[PubMed - indexed for MEDLINE]
7.

Effects of l-thyroxine administration, TSH-receptor antibodies and smoking on the risk of recurrence in Graves' hyperthyroidism treated with antithyroid drugs: a double-blind prospective randomized study.

Glinoer D, de Nayer P, Bex M; Belgian Collaborative Study Group on Graves' Disease.

Eur J Endocrinol. 2001 May;144(5):475-83.

PMID:
11331213
[PubMed - indexed for MEDLINE]
Free Article
8.

Antithyroid drug regimen for treating Graves' hyperthyroidism.

Abraham P, Avenell A, Watson WA, Park CM, Bevan JS.

Cochrane Database Syst Rev. 2005 Apr 18;(2):CD003420. Review. Update in: Cochrane Database Syst Rev. 2010;(1):CD003420.

PMID:
15846664
[PubMed - indexed for MEDLINE]
10.

A prospective randomized trial of antithyroid drug dose in Graves' disease therapy. European Multicenter Study Group on Antithyroid Drug Treatment.

Reinwein D, Benker G, Lazarus JH, Alexander WD.

J Clin Endocrinol Metab. 1993 Jun;76(6):1516-21.

PMID:
8501160
[PubMed - indexed for MEDLINE]
11.

Antithyroid drug regimen for treating Graves' hyperthyroidism.

Abraham P, Avenell A, Watson WA, Park CM, Bevan JS.

Cochrane Database Syst Rev. 2004;(2):CD003420. Review. Update in: Cochrane Database Syst Rev. 2005;(2):CD003420.

PMID:
15106202
[PubMed - indexed for MEDLINE]
12.

[Hyperthyroidism in Graves' disease--antithyroid drug treatment].

Schumm-Draeger PM.

Z Arztl Fortbild Qualitatssich. 1999 Apr;93 Suppl 1:41-5. Review. German.

PMID:
10355049
[PubMed - indexed for MEDLINE]
13.

Antithyroid drug and Graves' hyperthyroidism. Significance of treatment duration and TRAb determination on lasting remission.

García-Mayor RV, Páramo C, Luna Cano R, Pérez Mendez LF, Galofré JC, Andrade A.

J Endocrinol Invest. 1992 Dec;15(11):815-20.

PMID:
1283984
[PubMed - indexed for MEDLINE]
14.

Long-term carbimazole intake does not affect success rate of radioactive 131Iodine in treatment of Graves' hyperthyroidism.

El Refaei SM, Shawkat W.

Nucl Med Commun. 2008 Jul;29(7):642-8. doi: 10.1097/MNM.0b013e3282fda205.

PMID:
18528187
[PubMed - indexed for MEDLINE]
15.

Antithyroid drug regimen for treating Graves' hyperthyroidism.

Abraham P, Avenell A, Watson WA, Park CM, Bevan JS.

Cochrane Database Syst Rev. 2003;(4):CD003420. Review. Update in: Cochrane Database Syst Rev. 2004;(2):CD003420.

PMID:
14583975
[PubMed - indexed for MEDLINE]
16.

TSH-receptor autoimmunity in Graves' disease after therapy with anti-thyroid drugs, surgery, or radioiodine: a 5-year prospective randomized study.

Laurberg P, Wallin G, Tallstedt L, Abraham-Nordling M, Lundell G, Tørring O.

Eur J Endocrinol. 2008 Jan;158(1):69-75. doi: 10.1530/EJE-07-0450.

PMID:
18166819
[PubMed - indexed for MEDLINE]
Free Article
17.

The effect of propylthiouracil on subsequent radioactive iodine therapy in Graves' disease.

Hancock LD, Tuttle RM, LeMar H, Bauman J, Patience T.

Clin Endocrinol (Oxf). 1997 Oct;47(4):425-30.

PMID:
9404440
[PubMed - indexed for MEDLINE]
18.

Treatment outcome of Graves' disease in Thai children.

Somnuke PH, Pusuwan P, Likitmaskul S, Santiprabhob J, Sawathiparnich P.

J Med Assoc Thai. 2007 Sep;90(9):1815-20.

PMID:
17957924
[PubMed - indexed for MEDLINE]
19.

High dose of (131)I therapy for the treatment of hyperthyroidism caused by Graves' disease.

Alexander EK, Larsen PR.

J Clin Endocrinol Metab. 2002 Mar;87(3):1073-7.

PMID:
11889166
[PubMed - indexed for MEDLINE]
20.

Preoperative change of thyroid stimulating hormone receptor antibody level: possible marker for predicting recurrent hyperthyroidism in patients with Graves' disease after subtotal thyroidectomy.

Sugino K, Mimura T, Ozaki O, Iwasaki H, Wada N, Matsumoto A, Ito K.

World J Surg. 1996 Sep;20(7):801-6; discussion 806-7.

PMID:
8678954
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk